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ABSTRACT 
Soybean MON 87708 contains a single insert consisting of the dmo expression cassette. The DMO (dicamba 
mono-oxygenase) proteins confer tolerance to dicamba-based herbicides. Bioinformatic analyses of the inserted 
DNA and flanking regions do not raise safety issues. The levels of DMO proteins in soybean MON 87708 have 
been sufficiently analysed. The stability of the genetic modification has been demonstrated. No differences were 
identified in the compositional data of forage and seeds obtained from soybean MON 87708 or in its agronomic 
and phenotypic characteristics that would require further assessment with regard to safety by the GMO Panel. 
The safety assessment identified no concerns regarding the potential toxicity and allergenicity of the DMO 
proteins, or of soybean MON 87708. The compositional data indicating that soybean MON 87708 is as nutritious 
as non-GM soybean varieties were supported by the outcome of a chicken study. There are no indications of an 
increased likelihood of establishment and spread of feral GM soybean plants. Considering the scope of this 
application, potential interactions of soybean MON 87708 with the biotic and abiotic environment were not 
considered to be an issue. Environmental risks associated with an unlikely but theoretically possible horizontal 
gene transfer from soybean MON 87708 to bacteria have not been identified. The post-market environmental 
monitoring plan and reporting intervals are in line with the intended uses of soybean MON 87708. In conclusion, 
the GMO Panel considers that the information available for soybean MON 87708 addresses the scientific 
comments raised by the Member States, and that the soybean MON 87708, as described in this application, is as 
safe as its conventional counterpart and non-GM soybean reference varieties with respect to potential effects on 
human and animal health or the environment, in the context of its intended uses. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following the submission of an application (EFSA-GMO-NL-2011-93) under Regulation (EC) No 
1829/2003
4
 from Monsanto, the Panel on Genetically Modified Organisms of the European Food 
Safety Authority (EFSA GMO Panel) was asked to deliver a Scientific Opinion on the safety of 
genetically modified (GM) herbicide-tolerant soybean MON 87708 (Unique Identifier MON-877Ø8-
9) for food and feed uses, import and processing. 
In delivering its Scientific Opinion the EFSA GMO Panel considered the application EFSA-GMO-
NL-2011-93, additional information provided by the applicant, scientific comments submitted by the 
Member States and relevant scientific publications. The scope of application EFSA-GMO-NL-2011-
93 is for food and feed uses, import and processing of soybean MON 87708 within the European 
Union (EU), as for any other non-GM soybean, but excludes cultivation in the EU. The EFSA GMO 
Panel evaluated soybean MON 87708 with respect to the scope and the appropriate principles 
described in its Guidance Documents for the risk assessment of GM plants and derived food and feed, 
and on the post-market environmental monitoring of GM plants. The scientific evaluation included the 
molecular characterisation of the inserted DNA and the analysis of the expression of the corresponding 
proteins. An evaluation of the comparative analysis of compositional, phenotypic and agronomic 
characteristics was undertaken, and the safety of the newly expressed protein and the whole food/feed 
was evaluated with respect to potential toxicity, allergenicity and nutritional wholesomeness. 
Evaluation of the environmental impacts and of the post-market environmental monitoring plan was 
undertaken. 
The molecular characterisation data establish that the genetically modified soybean MON 87708 
contains one copy of an intact dmo expression cassette in a single locus. No other parts of the plasmid 
used for transformation are present in soybean MON 87708. The results of the bioinformatic analyses 
of the inserted DNA and the flanking regions do not raise safety issues. The levels of DMO proteins in 
soybean MON 87708 have been sufficiently analysed and the stability of the genetic modification has 
been demonstrated. 
The EFSA GMO Panel compared the compositional, phenotypic and agronomic characteristics of 
soybean MON 87708, the conventional counterpart (A3525) and other non-GM soybean reference 
varieties, and assessed all statistically significant differences between soybean MON 87708 and 
A3525 for which equivalence with the non-GM reference varieties could not be established. It is 
concluded that no differences were identified in the compositional data of forage and seeds obtained 
from soybean MON 87708 or in its agronomic and phenotypic characteristics that would require 
further assessment with regard to safety by the EFSA GMO Panel. 
The DMO proteins are degraded by proteolytic enzymes, and bioinformatics-supported studies 
demonstrated that these proteins show no similarity to known toxic and allergenic proteins. No 
toxicity of the DMO proteins was observed in 28-day and acute toxicity studies in mice. The result of 
a 90-day feeding study in rats with diets containing toasted defatted soybean meal from soybean 
MON 87708, its conventional counterpart or any of two non-GM soybean varieties did not raise safety 
concerns. There are no indications that the genetic modification might significantly change the overall 
allergenicity of soybean MON 87708 when compared with that of its conventional counterpart. The 
compositional data indicating that soybean MON 87708 is as nutritious as non-GM soybean varieties 
were supported by the outcome of a chicken study. In conclusion, the EFSA GMO Panel is of the 
opinion that soybean MON 87708 is as safe and as nutritious as its conventional counterpart and non-
GM reference varieties, in the context of its intended uses. 
The scope of application EFSA-GMO-NL-2011-93 is for food and feed uses, import and processing 
and does not include cultivation. Therefore, there is no requirement for scientific information on 
possible environmental effects associated with the cultivation of soybean MON 87708 in the EU. 
                                                     
4  Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. Official Journal of the European Communities, L268, 1–23. 
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There are no indications of an increased likelihood of establishment and spread of feral GM soybean 
plants in event of accidental release into the environment of viable soybean MON 87708 grains during 
transport and processing for food and feed uses. Considering its intended uses as food and feed, 
potential interactions of soybean MON 87708 with the biotic and abiotic environment were not 
considered to be an issue by the EFSA GMO Panel. The unlikely, but theoretically possible, transfer 
of the recombinant gene from soybean MON 87708 to environmental bacteria does not raise any 
safety concern because no selective advantage will be conferred on the recipients. The scope of the 
post-market environmental monitoring plan provided by the applicant is in line with the intended uses 
of soybean MON 87708. Furthermore, the EFSA GMO Panel agrees with the reporting intervals 
proposed by the applicant in the post-market environmental monitoring plan. 
In conclusion, the EFSA GMO Panel considers that the information available for soybean 
MON 87708 addresses the scientific issues indicated in the relevant Guidance Documents of the EFSA 
GMO Panel and the scientific comments raised by the Member States, and that soybean MON 87708, 
as described in this application, is as safe as its conventional counterpart and non-GM soybean 
reference varieties with respect to potential effects on human and animal health or the environment, in 
the context of its intended uses. 
It should be noted that the assessment of potential consumer health risks resulting from dicamba 
residues and its metabolites in soybean MON 87708 is under the remit of the EFSA Pesticides Unit. 
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BACKGROUND 
On 9 February 2011, EFSA received from the Dutch Competent Authority an application (Reference 
EFSA-GMO-NL-2011-93) for authorisation of the herbicide tolerant genetically modified soybean 
MON 87708 (Unique Identifier MON-877Ø8-9) for food and feed uses, import and processing, 
submitted by Monsanto within the framework of Regulation (EC) No 1829/2003 on genetically 
modified food and feed.
5
 
After receiving the application EFSA-GMO-NL-2011-93 and in accordance with Articles 5(2)(b) and 
17(2)b of Regulation (EC) No 1829/2003, EFSA informed the Member States and the European 
Commission (EC) and made the summary of the dossier publicly available on the EFSA website.
6
 
EFSA initiated a formal review of the application to check compliance with the requirements laid 
down in Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On 29 March 2011, EFSA 
received additional information requested under completeness check (on 18 March 2011). On 13 May 
2011, EFSA declared the application as valid in accordance with Article 6(1) and 18(1) of Regulation 
(EC) No 1829/2003. 
EFSA made the valid application available to the Member States and the EC and consulted nominated 
risk assessment bodies of the Member States, including the national Competent Authorities within the 
meaning of Directive 2001/18/EC
7
 following the requirements of Articles 6(4) and 18(4) of Regulation 
(EC) No 1829/2003, to request their scientific opinion. Member State had three months after the date 
of receipt of the valid application (until 13 August 2011) to make their opinion known. 
The Scientific Panel on Genetically Modified Organisms of EFSA (EFSA GMO Panel) carried out a 
scientific assessment of genetically modified soybean MON 87708 for food and feed uses, import and 
processing in accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003. The EFSA 
GMO Panel took into account the appropriate principles described in its guidelines for the risk 
assessment of GM plants and derived food and feed (EFSA 2006a, 2011a) and on the post-market 
environmental monitoring (PMEM) of GM plants (EFSA, 2006b, 2011b). Furthermore, the EFSA 
GMO Panel also took into consideration the scientific comments of Member States, the additional 
information provided by the applicant and the relevant scientific publications. 
On 10 August 2011, 17 August 2011, 10 February 2012, 5 July 2012, 7 November 2012, 11 February 
2013, 19 February 2013 and 13 May 2013, the EFSA GMO Panel asked for additional data on 
soybean MON 87708. The applicant provided the requested information on 18 October 2011, 14 
March 2012, 1 August 2012, 13 November 2012, 15 February 2013, 21 February 2013 and 6 June 
2013. After evaluation of the full data package, the EFSA GMO Panel finalised its risk assessment of 
soybean MON 87708. 
In giving its scientific opinion on GM soybean MON 87708 to the EC, the Member States and the 
applicant, and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA 
has endeavoured to respect a time limit of six months from the acknowledgement of the valid 
application. As additional information was requested by the EFSA GMO Panel, the time-limit of 6 
months was extended accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) 
No 1829/2003.  
According to Regulation (EC) No 1829/2003, this scientific opinion is to be seen as the report 
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall 
opinion in accordance with Articles 6(5) and 18(5).  
                                                     
5 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. Official Journal of the European Communities, L268, 1-23. 
6  http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2011-00122 
7  Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. Official Journal of the 
European Communities, L106, 1-38. 
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TERMS OF REFERENCE 
The EFSA GMO Panel was requested, to carry out a scientific risk assessment of the soybean 
MON 87708 for food and feed uses, import and processing in accordance with Articles 6(6) and 18(6) 
of Regulation (EC) No 1829/2003. 
Where applicable, any conditions or restrictions which should be imposed on the placing on the 
market and/or specific conditions or restrictions for use and handling, including post-market 
monitoring requirements based on the outcome of the risk assessment and, in the case of GMOs or 
food/feed containing or consisting of GMOs, conditions for the protection of particular 
ecosystems/environment and/or geographical areas should be indicated in accordance with Articles 
6(5)(e) and 18(5)e of Regulation (EC) No 1829/2003. 
The EFSA GMO Panel was not requested to give an opinion on information required under Annex II 
to the Cartagena Protocol. Furthermore, the EFSA GMO Panel did not consider proposals for labelling 
and methods of detection (including sampling and the identification of the specific transformation 
event in the food/feed and/or food/feed produced from it), which are matters related to risk 
management. 
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ASSESSMENT 
1. Introduction 
The genetically modified (GM) soybean MON 87708 (Unique Identifier MON-877Ø8-9) was assessed 
with respect to its scope, taking account of the appropriate principles described in the Guidance 
Documents of the EFSA GMO Panel for the risk assessment of GM plants and derived food and feed 
(EFSA, 2006a, 2011a), and on the post-market environmental monitoring of GM plants (EFSA, 
2006b, 2011b). The risk assessment presented here is based on the information provided in the 
application relating to soybean MON 87708 submitted in the EU, scientific comments raised by the 
Member States and relevant scientific publications. 
The scope of application EFSA-GMO-NL-2011-93 is for food and feed use, import and processing of 
soybean MON 87708 within the EU. Thus, soybean MON 87708 will be imported into the EU mixed 
with other soybean varieties and will be used as food or feed, or for the production of a large number 
of derived products, as any commercial soybean variety. The main product for human use is soybean 
oil. Around 10 % of the heat-processed (toasted) defatted soybean meal goes to production of soybean 
products for human consumption, including flours, soybean protein concentrates and various textured 
products simulating meats, seafood and cheeses. The rest of the toasted defatted soybean meal goes 
into animal feed, in the EU mainly feed for poultry, pig and cattle (OECD, 2001). Whole soybeans are 
used to produce soy sprouts, baked soybeans and roasted soybeans. There is also a limited direct use 
of soybeans as animal feeds.
8
 
Soybean MON 87708 was developed to confer tolerance to herbicides containing dicamba (3,6-
dichloro-2-methoxybenzoic acid).
9
 Dicamba tolerance is achieved by the expression of dicamba 
mono-oxygenase (DMO) proteins, which demethylate dicamba, producing 3,6-dichlorosalicylic acid 
and formaldehyde. It should be noted that the acceptable daily intake (ADI) proposed for the 
metabolite 3,6-dichlorosalicylic acid, which is produced in soybean MON 87708, is lower than the 
ADI proposed for dicamba.
10
 The assessment of potential consumer health risks resulting from 
dicamba residues and its metabolites in soybean MON 87708 is outside the remit of the EFSA GMO 
Panel and is currently ongoing
10
 in the EFSA Pesticides Unit. 
The genetic modification is intended to improve agronomic performance only and is not intended to 
influence the nutritional aspects, the processing characteristics and the overall use of soybean as a 
crop. 
2. Issues raised by Member States 
Issues raised by Member States are addressed in Annex G of the overall opinion
11
 and were taken into 
consideration during the evaluation of the risk assessment. 
3. Molecular characterisation 
3.1. Evaluation of relevant scientific data 
3.1.1. Transformation process and vector constructs12 
MON 87708 was developed by Agrobacterium tumefaciens (also know as Rhizobium radiobacter)-
mediated transformation of meristematic tissue from the embryos of germinated soybean A3525 
(Glycine max (L.) Merr.) seeds with plasmid vector PV-GMHT4355. The regeneration of the 
transformed tissue was achieved without a callus phase. 
                                                     
8 Technical dossier/Section D7.5. 
9 Technical dossier/Section D1. 
10  EFSA-Q-2011-01268: Dicamba - Application to modify the existing MRL in soybean. 
11 http://registerofquestions.efsa.europa.eu/ 
12 Technical dossier/Sections C and D1. 
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The plasmid PV-GMHT4355 contained two T-DNAs (T-DNA I and II): 
 The dmo expression cassette (T-DNA I), which confers tolerance to dicamba herbicide contains 
the following genetic elements between the right and left borders: PC1SV promoter from Peanut 
chlorotic streak caulimovirus; TEV, 5  non-translated region (leader sequence) from Tobacco etch 
virus, involved in the regulation of gene expression; RbcS encoding chloroplast transit (targeting) 
peptide and the first 24 amino acids of the mature ribulose-1,5-bisphosphate carboxylase 
oxygenase (RuBisCO) small subunit protein from pea (Pisum sativum); dmo, a derivative of the 
coding sequence of DMO from Stenotrophomonas maltophilia; E9, 3  non-translated region of 
pea RuBisCO small subunit, functioning as a polyadenylation signal. 
 The CP4 epsps cassette (T-DNA II), which confers glyphosate tolerance carries the following 
genetic elements between the right and left borders: FMV promoter from Figwort mosaic virus; 
DnaK 5  non-translated leader sequence from Petunia hybrida Hsp70 gene, involved in the 
regulation of gene expression; sequence encoding CTP2, a chloroplast transit (targeting) peptide 
from the shkG gene of Arabidopsis thaliana (shkG encodes EPSPS, 5-enolpyruvylshikimate-3 -
phosphate synthase); CP4 epsps, a codon-optimised coding sequence of aroA gene from 
Agrobacterium sp. strain CP4 coding for CP4 EPSPS;  E9, 3  non-translated region of pea 
RuBisCO small subunit, functioning as a polyadenylation signal. 
The vector backbone contained elements necessary for the maintenance and selection of the plasmid in 
bacteria: oriV, the origin of replication from the broad-host-range plasmid RK2 for the maintenance of 
plasmid vector in Agrobacterium; rop, repressor of primer protein from ColE1 plasmid, playing a role 
in the maintenance of plasmid copy number in Escherichia coli; ori-pBR322, the origin of replication 
from plasmid pBR322 and required for the maintenance of PV-GMHT4355 in E. coli; bacterial 
promoter, coding and 3  non-translated sequences of aadA from tansposon Tn7, an aminoglycoside-
modifying enzyme conferring resistance to spectinomycin and streptomycin for selection of the 
plasmid in E. coli and Agrobacterium. 
During transformation, both T-DNAs were inserted into the soybean genome. Glyphosate tolerance 
conferred by the CP4 EPSPS protein derived from T-DNA II served as a marker during the initial 
selection of transformants. The T-DNA II insert was segregated away from the soybean during the 
conventional breeding process. 
3.1.2. Transgene constructs in the genetically modified plant13 
Southern analysis was used to determine the number of copies and insertion sites, and to confirm the 
presence or absence of vector backbone sequences. The approach used was acceptable in terms of both 
coverage and sensitivity. 
Southern analyses indicated that soybean event MON 87708 contains a single insert with one copy of 
the intact DMO expression cassette. No elements from T-DNA II or the vector backbone were 
detected. Southern analyses of genomic DNA from soybean MON 87708 were performed using 
appropriate combinations of restriction endonucleases and 10 overlapping probes covering the whole 
plasmid. The probes corresponding to the different elements of the two T-DNAs showed the expected 
hybridisation signals, whereas no signal was observed for any of the probes corresponding to the 
vector backbone. 
The nucleotide sequence of the insert as well as both 5  and 3  flanking regions were determined. 
Comparisons with the conventional soybean genomic sequences indicated that, in soybean 
MON 87708 there was an 899 bp deletion, a 128 bp insertion adjacent to the 5  of the insert, and a 35-
bp insertion adjacent to the 3  of the insert. Bioinformatic analyses of the genomic sequences flanking 
the insert and the deleted region were carried out to assess any potential interruption of known 
                                                     
13 Technical dossier/Section D2. 
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soybean genes. BLASTN searches were performed against the GenBank EST (Expressed Sequence 
Tag) database and non-redundant nucleotide database and a BLASTX search against the non-
redundant amino acid database. The results did not indicate the interruption of any gene in soybean 
MON 87708, and also confirmed that the insert is located in the nuclear genome. 
In order to assess whether the open reading frames (ORFs) present within the insert and spanning the 
junction sites raise any safety issue, their putative translation products were compared to the GenBank 
protein database for all proteins and its subset for toxins, as well as to the FARRP database for 
allergens.
14
 In addition, the presence of eight amino acid perfect matches between known allergens 
and the putative new ORFs was examined. No alignment met or exceeded the Codex Alimentarius 
(2003) and the EFSA (2010) threshold for potential allergenicity and no relevant similarities to known 
toxic proteins were found. These analyses support the conclusion that, even in the unlikely event that 
any of the new ORFs at the junctions or present within the insert were translated, this would not raise a 
safety issue. 
3.2. Information on the expression of the insert15 
The DMO precursor protein undergoes alternative processing, resulting in two monomeric forms 
(DMO and DMO+27). The active DMO enzyme is a trimer. Total DMO proteins levels were analysed 
by an enzyme-linked immunosorbent assay (ELISA) using leaf, root, forage and mature seed 
materials, from replicated field trials across eight soybean-growing regions in the USA in 2009. The 
plants were treated with dicamba. Considering the scope of the application, the DMO proteins levels 
in seed and forage are considered most relevant. The mean DMO level was 40 μg/g dry weight (dw) 
(range 21–65 μg/g dw) in mature seeds. In forage, the mean DMO level was 32 μg/g dw (range 15–54 
μg/g dw). 
3.2.1. Inheritance and stability of inserted DNA16 
Genetic stability of the inserted DNA was studied over five generations by Southern analysis. The 
restriction enzyme/probe combinations used were sufficient to conclude that all of the generations 
tested retained the single copy insert together with its flanking regions. The insert is therefore stably 
inherited. 
Supporting evidence for the stability was obtained by a quantitative, structure-specific endonuclease-
based assay over three generations in approximately 3200 plants. This analysis also provided 
information on the zygosity of the plants which was consistent with a single genetic locus segregating 
according to Mendelian principles. 
3.3. Conclusion 
Molecular characterisation data establish that soybean MON 87708 contains a single insert. 
Bioinformatic analyses did not reveal disruption of known soybean genes or the formation of ORFs 
that would raise a hazard. Levels of the newly expressed DMO proteins have been sufficiently 
analysed, and the stability of the inserted DNA was confirmed over several generations. The EFSA 
GMO Panel considers that all of the molecular data sets are sufficient for the molecular 
characterisation. 
                                                     
14 Technical dossier/Section D3 (c). 
15 Technical dossier/Sections D3 (a), (b) and (d). 
16 Technical dossier/Section D5. 
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4. Comparative analysis 
4.1. Evaluation of relevant scientific data 
4.1.1 Production of material for the comparative assessment17 
The application EFSA-GMO-NL-2011-93 for food and feed use, import and processing of soybean 
MON 87708 within the EU presented compositional data on seed and forage material collected in a 
field trial performed in the USA in 2009. Some aspects of these studies have been published (Harrison 
et al., 2011). The field trials compared the composition of soybean MON 87708 with a suitable 
conventional counterpart. The conventional counterpart was the non-transgenic Asgrow variety 
A3525, which was the soybean variety originally transformed to establish transformation event 
MON 87708. 
The field trial was performed at eight sites within soybean cultivation areas in the USA. At each site 
the following test materials were grown in a randomized complete block design with four replicates: 
soybean MON 87708 (treated and untreated with dicamba), the conventional counterpart (soybean 
A3525) and three non-GM soybean reference varieties. All test materials were treated with 
conventional herbicides. Overall the field trials included 14 non-GM soybean reference varieties.
18
 
The test materials were characterised by event-specific polymerase chain reaction (PCR) for the 
presence or absence of the MON 87708 event. One replication of the conventional counterpart at one 
site (Indiana) was excluded from the analysis because of the adventitious presence of a different GM 
soybean event coming from a GM soybean grown at the same site. Forage and seed material were 
missing from one of the four replicates of the conventional counterpart at one site (Kansas), and from 
one of the four replicates of soybean MON 87708 at one site (Iowa). 
4.1.2 Compositional analysis19 
On request of the EFSA GMO Panel, the applicant analysed the compositional data using the most 
recent statistical methodology recommended by the EFSA GMO Panel (EFSA, 2010, 2011a). This 
recommends a test of difference to determine whether the GM plant is different from its conventional 
counterpart, and a test of equivalence to determine whether the GM plant falls within the range of 
natural variation estimated from the non-GM soybean reference varieties. As described in EFSA 
2011a, the result of the equivalence test is categorised into four possible outcomes to facilitate drawing 
appropriate conclusions with respect to the presence or absence of equivalence. These four categories 
are: category I, indicating full equivalence; category II, indicating that equivalence is more likely than 
non-equivalence; category III, indicating that non-equivalence is more likely than equivalence; and 
category IV, indicating non-equivalence. 
The key constituents included in the compositional analysis of soybean seeds and forage were selected 
according to OECD recommendations (OECD, 2001). Soybean seeds were harvested and analysed for 
proximates (protein, fat, ash, and moisture, and carbohydrate by calculation), fibre fractions (acid 
detergent fibre (ADF) and neutral detergent fibre (NDF)), amino acids, fatty acids, vitamin E, anti-
nutrients (i.e. phytic acid, trypsin inhibitor, lectins, stachyose and raffinose) and other secondary 
metabolites (isoflavones). Forage was analysed for proximates and for fibre fractions (ADF, NDF). In 
total, 56 parameters were analysed in seed, seven of which were also analysed in forage. Fourteen 
                                                     
17 Technical dossier/Sections C and D7.1–7.3 and additional information received October 2011, March 2012 and August 
2012. 
18 The non-GM reference materials were FS3591; Crows C3908; NK S38-T8; Croplan HT3596STS; Midland 363; Stewart 
SB3454; Quality Plus 365C; Channel Bio 3461; Pioneer 93M52; NK 32Z3; Garst 3585N; Channel Bio 37002; Crows 
C37003N; Wilken 3316. 
19 Technical dossier/Section D7.1 and additional information received October 2011, March 2012 and August 2012. 
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parameters having more than 50 % of the observations below the limit of quantification were excluded 
from the analysis.
20
  
Samples sprayed with conventional herbicides showed statistically significant differences between 
soybean MON 87708 and its conventional counterpart for 20 parameters in seeds (protein and 
carbohydrates; the amino acids arginine, aspartic acid, glutamic acid, histidine, isoleucine, leucine, 
lysine, phenylalanine, proline and valine; and the fatty acids C16:0 palmitic acid, C18:1 oleic acid, 
C18:3 linolenic acid, C20:1 eicosenoic acid and C22:0 behenic acid; and the anti-nutrients phytic acid, 
trypsin inhibitors and stachyose), and for two parameters in forage (protein and carbohydrate). The test 
of equivalence indicated that the level of 18 of these parameters in soybean MON 87708 fell within 
the equivalence limits established from the non-GM soybean reference varieties. Equivalence could 
not be established for four parameters in seeds (equivalence category III - EFSA, 2011). These were 
total fat (MON 87708 16.45% dw, A3525 16.48% dw, reference varieties 18.41% dw), carbohydrates 
(MON 87708 38.56% dw, A3525 37.47% dw, reference varieties 36.59% dw), 20:1 eicosenoic acid 
(MON 87708 0.11% total fatty acids (FA), A3525 0.12% total FA, reference varieties 0.15% total 
FA), and 22:0 behenic acid (MON 87708 0.27% total FA, A3525 0.28% total FA, reference varieties 
0.32% total FA). The test of equivalence could not be performed on trypsin inhibitor because of the 
lack of variation among the non-GM soybean reference varieties for this compound.  
The EFSA GMO Panel evaluated the parameters for which equivalence could not be demonstrated and 
concluded that no further assessment was needed as their biochemical role is well known and the 
magnitude of the reported levels lack relevance from a food and feed safety and nutritional point of 
view.  
Samples of soybean MON 87708 sprayed with dicamba in addition to required conventional 
herbicides and the conventional counterpart sprayed only with required conventional herbicide showed 
statistically significant differences for 21 parameters in seeds (protein, moisture and carbohydrates, the 
amino acids arginine, aspartic acid, glutamic acid, histidine, leucine, phenylalanine and proline, the 
fatty acids 16:0 palmitic acid, 18:1 oleic acid, 18:2 linoleic acid, 18:3 linolenic acid, 20:1 eicosenoic 
acid, and 22:0 behenic acid, and vitamin E, phytic acid, stachyose, genistein and daidzein) and for one 
parameter in forage (total fat). The test of equivalence indicated that the level of 16 of these 
parameters in soybean MON 87708 fell within the equivalence limits established from the non-GM 
soybean reference varieties, whereas equivalence could not be established for five parameters 
(equivalence category III - EFSA, 2011) and therefore required further evaluation. These were total fat 
(MON 87708 16.33% dw, A3525 16.48% dw, reference varieties 18.41% dw), carbohydrates 
(MON 87708 38.50% dw, A3525 37.47% dw, reference varieties 36.59% dw), 20:1 eicosenoic acid 
(MON 87708 0.11% total FA, A3525 0.12% total FA, reference varieties 0.15% total FA), and 22:0 
behenic acid (MON 87708 0.27% total FA, A3525 0.28% total FA, reference varieties 0.32% total 
FA) in seeds, and protein (MON 87708 24.03% dw, A3525 23.81% dw, reference varieties 21.64% 
dw) in forage. The test of equivalence could not be performed on trypsin inhibitor because of the lack 
of variation among the non-GM soybean reference varieties, however the test of difference was not 
significant.  
The EFSA GMO Panel further evaluated these parameters for which equivalence could not be 
demonstrated and concluded that no further assessment was needed as their biochemical role is well 
known and the magnitude of the reported levels lack relevance from a food and feed safety and 
nutritional point of view.  
                                                     
20 These were C8:0 caprylic acid, C10:0 capric acid, C12:0 lauric acid, C14:0 myristic acid, C14:1 myristoleic acid, C15:0 
pentadecanoic acid, C15:1 pentadecenoic acid, C16:1 palmitoleic acid, C17:0 heptadecanoic acid, C17:1 heptadecenoic 
acid, C18:3 gamma-linolenic acid, C20:2 eicosadienoic acid, C20:3 eicosatrienoic acid and C20:4 arachidonic acid. 
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4.1.3 Agronomic and phenotypic characteristics21 
Based on data collected at the eight sites in the USA field trial in 2009 (the same field trial used to 
collect seeds and forage for compositional studies: see Section 4.1.1 and 4.1.2), the applicant 
performed a comparative assessment of the phenotypic and agronomic characteristics of soybean 
MON 87708 and its conventional counterpart (soybean A3525). The phenotypic and agronomic 
characteristics evaluated were early stand count, seedling vigour, days to 50 % flowering, flower 
colour, plant height, lodging, pod shattering, final stand count, seed moisture, 100 seed weight, yield, 
and plant growth stages. In addition, specific studies were carried out to investigate pollen viability, 
pollen diameter, and dormancy/germination. 
On request of the EFSA GMO Panel, the applicant analysed the data on phenotypic and agronomic 
characteristics using the most recent statistical methodology recommended by the EFSA GMO Panel 
(EFSA, 2010, 2011a). The test of difference of phenotypic and agronomic characteristics identified 
statistically significant differences between soybean MON 87708 and its conventional counterpart for 
only one endpoint (100 seed weight). Soybean MON 87708 both sprayed and not sprayed with 
dicamba had a lower 100 seed weight than its conventional counterpart (in both cases 14.6 g vs. 
15.6 g). The equivalence test indicated that all the analysed characteristics fell within the equivalence 
limits established from the non-GM soybean reference varieties, except for 100 seed weight (100 seed 
weight: 15.0-17.7 g). Equivalence could not be established for 100 seed weight (equivalence category 
III - EFSA, 2011); therefore, this parameter required further evaluation.  
The difference in 100 seed weight might be either incidental or indicative of unintended effects due to 
the genetic modification. The applicant was unable to explain why non-equivalence between the GM 
soybean and the non-GM soybean reference varieties had occurred. However, considering the 
magnitude of the difference in 100 seeds weight, its inherent variability and lack of impact on other 
parameters investigated, including yield, the EFSA GMO Panel concludes that this difference does not 
pose safety concerns in the context of the scope of this application.  
A specific study was performed at one of the field trial sites to investigate pollen morphology and 
viability. There was no difference in percent viable pollen, pollen diameter and pollen morphology 
between soybean MON 87708 and the conventional counterpart, soybean A3525.  
A study focusing on seed germination and dormancy characteristics was performed in germination 
chambers using seeds collected from three field trial sites. No difference in percent viable hard seed or 
percent viable firm-swollen seed was observed between seeds of soybean MON 87708 and the 
conventional counterpart tested at six different temperature regimes. The percent germinated seed of 
soybean MON 87708 was lower than that of the conventional counterpart at 10 
o
C (98.9 % vs. 99.7 %) 
and 10/30 
o
C (98.6 % vs. 99.7 %), whereas no difference was observed at 20 
o
C, 30 
o
C, 10/20 
o
C and 
20/30 
o
C. A higher percent dead seed was observed for soybean MON 87708 than for the conventional 
counterpart at 10
o
C (0.8 % vs. 0.2 %) and 10/30 
o
C (1.4 % vs. 0.3 %). As these differences were small 
in magnitude and fell within the range estimated from the non-GM soybean reference varieties, the 
EFSA GMO Panel did not find these observations indicative of relevant alterations in germination 
characteristics. 
Comparable responses to abiotic stressors such as cold, compaction, drought, flood, frost, hail, nutrient 
deficiency and wind were observed. These data on the environmental interaction of soybean 
MON 87708 as compared with the conventional counterpart were obtained in materials that had 
received equivalent maintenance herbicide treatments, i.e. they were not treated with dicamba. No 
differences between soybean MON 87708 and the conventional counterpart for any of the diseases on 
this legume crop were observed. 
                                                     
21 Technical dossier/Section D4 and additional information October 2011, March 2012 and August 2012. 
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Overall, the EFSA GMO Panel found these differences small in magnitude and unlikely to be 
biologically meaningful in relation to an adverse environmental impact of soybean MON 87708 
compared with the conventional counterpart. 
4.2. Conclusion 
Based on the information available, it is concluded that no differences were identified in the 
compositional data of forage and seeds obtained from soybean MON 87708 or in its agronomic and 
phenotypic characteristics that would require further assessment with regard to safety by the EFSA 
GMO Panel. 
5. Food/feed safety assessment 
5.1. Evaluation of relevant scientific data 
5.1.1. Effects of processing22 
Soybean MON 87708 will be used for production and manufacturing of food and feed products in the 
same way as any other commercial soybean variety. Taking into account the compositional analysis, 
providing no indication of biologically relevant compositional changes except for the expression of the 
DMO proteins in soybean MON 87708, the EFSA GMO Panel has no reason to assume that the 
characteristics of soybean MON 87708 and derived processed products would be different from those 
products derived from conventional soybean varieties, except for the presence of the DMO proteins. 
The three major processed fractions produced from whole soybean are oil, protein-rich meal and 
lecithin. The processing to produce these fractions on a pilot scale, which included heat treatment, 
resulted in severe loss of the DMO activity.
23
 
Heat stability of the DMO proteins 
On request of the EFSA GMO Panel, the applicant provided information on the thermal stability of the 
DMO enzymes.
23
 The stability to heat of aqueous solutions of the DMO proteins was assessed by 
measuring DMO activity and its intactness studied by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). As expected, the DMO enzymes were denatured at elevated 
temperatures. Complete loss of activity was found after incubation at 55
o
C and above. SDS-PAGE 
demonstrated that incubation of DMO at 55 
o
C had no effect on protein size. Incubation for 30 minutes 
at 75 
o
C or at higher temperatures (95 
o
C) resulted in a visible reduction in DMO protein band 
intensity.  
5.1.2. Toxicology24 
5.1.2.1. Protein used for safety assessment 
As described previously, soybean MON 87708 expresses two versions of the monomer dicamba 
mono-oxygenase (DMO) protein, DMO and DMO+27 (see Section 3.1.3). The DMO proteins used in 
the resistance to degradation studies, the study on acute oral toxicity and some of the substrate 
specificity studies were purified directly from seeds of soybean MON 87708. On the other hand, the 
28-day repeated-dose toxicity study and some of the substrate specificity studies were performed with 
DMO proteins produced in E. coli. The characterisation of the DMO and DMO+27 protein variants, 
with regard to physico-chemical characteristics and functional activity, was performed with the 
individual proteins and/or with a protein mixture. The molecular weights were determined by SDS-
PAGE, the identity and immunoreactivity with immunoblot analysis; partial amino acid sequencing 
was achieved by N-terminal sequence analysis and proteolytic peptide mapping by matrix-assisted 
laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry. These analyses were 
                                                     
22 Technical dossier/Section D7.6. 
23 Additional information October 2011. 
24 Technical dossier/Section D7.8 and additional information October 2011, March 2012 and August 2012. 
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complemented with the determination of both glycosylation status and functional activity. Together 
the studies confirmed the structural and functional equivalence of the two DMO proteins expressed in 
soybean MON 87708 with the corresponding proteins expressed in E. coli. 
5.1.2.2. Toxicological assessment of expressed novel proteins in soybean MON 8770825 
The DMO proteins in soybean MON 87708 are derived from the bacterium Stenotrophomonas 
maltophilia, which is ubiquitous in the environment. Occasionally, it has been found in clinical 
isolates (Denton, 1998).  
Crystallographic studies demonstrated the role of the carboxylic group of dicamba in binding to the 
active site of DMO, and the chloride atoms in providing the correct orientation. The applicant 
identified a number of naturally occurring benzoic, phenolic and phenylpropanoic acids which showed 
elements of structural similarities with dicamba and tested these in an assay positive for dicamba 
demethylation. No evidence of catabolism was seen with any other potential substrate tested, 
indicating a high specificity of the DMO for dicamba.
26
 
(a) Bioinformatics studies 
Bioinformatic analyses
27
 of the amino acid sequence of the DMO protein expressed in soybean 
MON 87708 revealed no significant similarities to known toxic proteins. 
(b) Resistance to degradation by proteolytic enzymes
28
 
The resistance to degradation by pepsin of DMO proteins (DMO and DMO+27) produced and purified 
from soybean seeds of MON 87708 (purity 81%) was measured in solutions containing pepsin and the 
test protein at pH 1.2. The integrity of the test protein was analysed by gel electrophoresis followed by 
protein staining and Western analysis. No DMO proteins were detected within 30 seconds of 
incubation. A 21-kDa fragment present in the DMO enzyme preparation was stable during the 
digestion with pepsin and appeared as weakly stained bands on the colloidal blue gel staining gels. 
However, this fragment was shown, by N-terminal sequencing, to be a stable impurity in the DMO 
preparation from soybean MON 87708 and not to derive from the DMO enzyme.  
The resistance of the DMO proteins to degradation by pancreatin was also assessed in solutions 
containing pancreatin and the test protein at pH 7.5. The integrity of the test protein was analysed by 
gel electrophoresis followed by Western analysis. No DMO proteins were detected within five minutes 
of incubation. The EFSA GMO Panel notes that resistance to degradation by pancreatin is not required 
by either the EFSA Guidance Document (EFSA, 2006a) or Codex Alimentarius (CAC, 2009). 
(c) Acute toxicity testing 
The DMO proteins (DMO and DMO+27) extracted from seeds of soybean MON 87708 induced no 
adverse effects in an acute oral toxicity study in CD-1 mice administered a single dose of 
140 mg/kg bw. 
The EFSA GMO Panel is of the opinion that acute toxicity testing of the newly expressed proteins is 
of little additional value for the risk assessment of the repeated consumption of food and feed from 
GM plants by humans and animals. 
                                                     
25 Technical dossier/Section D7.8.1. 
26 Technical dossier/Section D7.8.1 and additional information July 2012, November 2012. 
27 Technical dossier/Section D7.8.1 and additional information February 2013. 
28 Technical dossier/Section D7.8.1. 
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(d) Repeated-dose feeding toxicity study
29
 
On request of the EFSA GMO Panel, the applicant supplied a 28-day feeding toxicity study in mice 
with a mixture of the DMO and DMO+27 proteins supplied in the diet in a ratio approximately equal 
to the one at which they occur in soybean MON 87708 (i.e. 2:3).  The study was conducted in 
accordance with the OECD Guideline 407 on individually housed Crl:CD-1 mice (14 mice per sex per 
group) fed diets targeted to administer 0, 17, 51 or 171 mg DMO proteins/kg bw per day (actual doses: 
0, 17.5, 52.4 and 174 mg/kg bw per day in males; 0, 15.5, 53 and 179.7 mg/kg bw per day in females). 
The animals were observed regularly for clinical signs, and feed consumption and body weights were 
recorded. At the end of the treatment period, haematological and serum chemistry analyses were 
performed. All animals were sacrificed and underwent a detailed necropsy examination with selected 
organs weighed. Tissues from all animals in the high-dose and control groups were subjected to a 
comprehensive histological examination. Data for the test groups were compared with those of the 
control group and, when relevant, also with historical control data.  
Administration of DMO proteins did not induce any deaths or clinically relevant findings at any of the 
dose levels. There were no relevant differences in mean body weight, body weight gain or food 
consumption. The only statistically significant difference in the clinical pathology parameters assessed 
was an incidental higher mean absolute neutrophil count in males of the high-dose group, which was 
mainly driven by an unusually high value in one animal showing incidental inflammation of the skin. 
A slightly significantly higher mean spleen weight (relative to body weight) was seen in a male group 
given the high dose than in the control group; this was not associated with histopathological changes 
and considered the expression of biological variability. No macroscopic or microscopic findings in the 
examined organs and tissues attributable to the test material were reported. The highest dose 
administered in this study, i.e. 174 mg/kg bw per day in males and 179.7 mg/kg bw per day in females, 
is considered the no observed adverse effect level (NOAEL). 
Assuming an intake of 200 g of soybean per 70 kg adult per day in the EU and that all soybean 
consumed is derived from soybean MON 87708, the daily intake of DMO proteins would be in the 
region of 110 g/kg bw. The highest estimated intake of DMO proteins in adults is about 1000-fold 
lower than the NOAEL from the 28-day feeding study. 
5.1.2.3. Animal feeding studies30 
(a) Subchronic toxicity study in rats31  
A 90-day rat feeding study was performed using a protocol adapted from OECD Guideline 408. 
Individually housed Crl:CD[SD] rats were assigned to eight groups (12 rats per sex per group) and 
offered ad libitum diets containing 15% or 30% toasted and defatted soybean meal respectively from 
soybean MON 87708 (test groups fed diets containing soybean MON 87708 treated with the intended 
herbicide dicamba),
32
 from the conventional counterpart (control groups), or from two commercial 
non-GM varieties (reference groups). Analysis of soybean meals showed their nutritional equivalence. 
Diets were adjusted to contain approximately equal levels of calories, protein, and other nutrients 
(analytically confirmed) and to be balanced for rats. Data from the groups fed diets containing soybean 
MON 87708 were compared with their corresponding control groups using a one-way parametric 
analysis of variance for all quantitative endpoints.
33
    
All animals appeared healthy throughout the study. Body weight gain was transiently lower (up to 
11 %; statistically significant) in females given the diet containing 15 % soybean MON 87708 (weeks 
0-6) and in males given the diet containing 30 % soybean MON 87708 (weeks 0-3); partial recovery 
                                                     
29 Additional information March 2012. 
30 Technical dossier/Section D7.8.4. 
31 Technical dossier/Section D7.8.4 and additional information June 2013. 
32 Additional information June 2013. 
33 Additional information June 2013. 
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was seen during the course of the study, resulting in a minimally lower cumulative body weight gain 
in rats fed diets containing soybean MON 87708 than in the corresponding controls (4.4 % in females, 
3.8 % in males respectively). These changes are not considered relevant as they were minimal, were 
not accompanied by significant differences in body weight and were within, or close to,  the ranges of 
groups fed reference varieties (the mean cumulative body weight gain in grams for females given 
15 % diet was: control 136, test diet 130 and reference varieties 127-145; in the case of males fed 30 
% diets it was: controls 338, test diet 325 and reference varieties 330-350). No biologically relevant 
differences in feed intake were seen among groups. 
Statistically significant differences in clinical pathology and urinalysis parameters between rats fed 
diets containing soybean MON 87708 and control animals (i.e. lower mean absolute monocytes counts 
in females fed the 15 % MON 87708 diet; higher mean percent eosinophils, higher alanine 
aminotransferase activity and serum chloride levels in male rats fed 30 % MON 87708; changes in 
urinary specific gravity, pH and volume in females fed 15 % test diet; and lower spleen weight in 
female rats given diets containing 15 % soybean MON 87708) were considered incidental and not 
relevant because the differences were minimal, were not associated with changes in related parameters 
or in histopathology, and were within the range of reference dietary groups and/or  historical control 
data. At macroscopic or microscopic examination (histopathology on rats given 30 % inclusion rate 
diets) no MON 87708-diet related findings were observed, and all the detected changes were 
consistent with the background pathology of rats of this strain and age.  
(b) Chicken feeding study 
The applicant provided a 42-day broiler chicken feeding study,
34
 in which the growth of birds given 
diets containing soybean meal produced from soybean MON 87708 (treated with dicamba)
35
 was 
compared with that of birds given meal prepared from the conventional counterpart (soybean A3525) 
and another six commercial non-GM soybean varieties. A total of 960 one-day-old broilers 
(Cobb × Cobb 500) were assigned to one of the eight treatments, each treatment initially consisting of 
10 replicate pens of 12 birds, reduced to 10 birds per pen (five male and five females replicates) on 
day 7, under a randomized complete block structure. 
Each diet consisted predominantly of one of the eight soybean meals, maize grain and maize gluten. 
The main dietary constituents were analysed for protein, moisture, and amino acids prior to diet 
preparation to formulate isocaloric diets with a similar amount of soybean meal. The soybean content 
varied with the age of the birds starting with 32.5 % w/w for the first 21 days of feeding, and reducing 
to 29.5-30.5 % during the final stages of growth. The diets, formulated based on nutrient requirements 
recommended by the National Research Council (NRC, 1994) were analysed for crude nutrients, 
minerals, amino acids, fatty acids and antinutrients. Diets were shown to be essentially free of 
pesticide residues
36
 and mycotoxins. 
Body weight, weight gain, feed intake and feed to gain ratio were measured or calculated at the end of 
the trial. Birds were then killed, processed and analysed for carcase yield. Data were subject first to a 
two-factor (diet and sex) analysis of variance. When no interaction was detected, the test group was 
evaluated against the control and reference groups together. This was done using a mixed linear model 
analysis.  
No significant differences in performance, carcase yield or the analysis of breast and thigh meat was 
observed when birds fed MON 87708 meal were compared with birds fed meal from either the control 
or the non-GM soybean varieties. Since body weight showed a significant diet by sex interaction, data 
were analysed separately for each sex. Final body weight, daily weight gain and feed intake were 
significantly lower in female birds fed with MON 87708, but not in male birds. The differences 
                                                     
34 Technical dossier/MSL0022551 (2010) & RAR-10-030 (2010). 
35 Additional information June 2013. 
36 Tested pesticides are organophosphates, organonitrogens, organochlorinated pesticides, N-methylcarbamate pesticides. 
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observed for females, although significant, were small (for example, body weight differing only by 
80 g in a 2.3-kg bird). Furthermore, the feed to gain ratio was not significantly different between 
sexes. 
Diets containing the various soybean meals were designed to deliver the same nutrition and 
consequently, the growth of birds given diets containing soybean meal produced from soybean 
MON 87708 was not expected to differ significantly from that of birds given meal prepared from the 
conventional counterpart soybean A3525. This held true for male birds, confirming the expectation 
that no unintended effects of a magnitude sufficient to affect growth had been introduced following 
the genetic modification. The differences observed for female birds were not considered to be of 
biological significance because the feed to gain ratio was not significantly different between sexes or 
between treatment groups. 
5.1.3. Allergenicity37 
The strategies used when assessing the potential allergenic risk focus on the characterisation of the 
source of the recombinant protein, the potential of the newly expressed protein to induce sensitisation 
or to elicit allergic reactions in already sensitised persons and whether the transformation may have 
altered the allergenic properties of the modified plant.  
5.1.3.1. Assessment of allergenicity of the newly expressed proteins38 
A weight-of-evidence approach is followed, taking into account all the information obtained with 
various test methods, since no single experimental method yields decisive evidence for allergenicity 
(CAC, 2009; EFSA, 2006a, 2011a). 
The dmo gene originates from Stenotrophomonas maltophilia, an aerobic, non-fermentative, Gram-
negative bacterium present in the environment as well as in humans. The bacterium has not been 
reported to give rise to allergenicity. The total amount of DMO in seed, the most important food 
material from soybean, reaches a level of 40 g/g dry weight (i.e. around 0.01 % of total soybean 
protein) in both dicamba-treated and non-treated soybeans. 
Bioinformatic analyses
39
 of the amino acid sequence of the DMO+27 protein (which contains the 
DMO amino acid sequence), using the criterion of 35 % identity in a window of 80 amino acids, 
revealed no significant similarities to known allergens. In addition, the applicant performed analyses 
searching for matches of eight contiguous identical amino acid sequences between the DMO+27 
protein and known allergens, and confirmed the outcome of the previous bioinformatic analyses. 
The studies on resistance to proteolytic enzymes of the newly expressed proteins have been described 
in Section 5.1.2.2(b).  
Based on all available information, the EFSA GMO Panel considers that there are no indications that 
the newly expressed DMO proteins in soybean MON 87708 may be allergenic in the intended 
conditions of use. 
5.1.3.2. Assessment of allergenicity of the whole GM plant or crop40 
Allergenicity of the whole GM plant could be increased (as an unintended effect) as a result of the 
genetic modification, for example through qualitative or quantitative modifications of the pattern of 
expression of endogenous allergenic proteins.  
                                                     
37 Technical dossier/Section D7.9. 
38 Technical dossier/Section D7.9.1. and additional information February 2013. 
39 Additional information February 2013. 
40 Technical dossier/Section 7.9.2. 
Scientific Opinion on genetically modified soybean MON 87708 
 
EFSA Journal 2013;11(10):3355 19 
According to the EFSA GMO Panel Guidance Documents (EFSA, 2006a, 2011a), when the plant 
receiving the introduced gene is known to be allergenic, the applicant should test any potential change 
in the allergenicity of the whole GM plant by comparing the allergen repertoire with that of its 
appropriate comparator(s). In this context, soybean is also considered a common allergenic food.
41
 
The applicant performed in vitro allergenicity studies with extracts of soybeans MON 87708, its 
conventional counterpart (soybean A3525), and 17 non-GM reference varieties. The IgE binding of 
soybean proteins to sera from 13 individuals clinically documented to be allergic to soybean, and from 
five non-allergic individuals, was quantified using an ELISA method to investigate whether the 
allergenicity potential of soybean MON 87708 is altered in comparison with that of its conventional 
counterpart and the non-GM reference varieties. The sera from allergic individuals had similar 
reactivity to proteins in extracts from soybean MON 87708 and the conventional counterpart.  
In addition and to further address the potential for changes in endogenous allergen repertoire of 
soybean MON 87708, the applicant supplied the results of two-dimensional (2D) SDS-PAGE analysis 
of extracts of soybean MON 87708 and its conventional counterpart followed by Western blotting 
with individual sera from eight individuals allergic to soybean. These studies demonstrated no 
meaningful differences in the IgE binding patterns between the extracts of proteins derived from 
soybean MON 87708 and its conventional counterpart.  
In the context of the present application, and based on all the available information, the EFSA GMO 
Panel concludes that there are no indications that the genetic modification might significantly change 
the overall allergenicity of soybean MON 87708 when compared with that of its conventional 
counterpart.  
5.1.4. Nutritional assessment of GM food/feed42 
The intended trait of soybean MON 87708 is herbicide tolerance, with no intention to alter the 
nutritional parameters. The evaluation of compositional data, indicating that soybean MON 87708 is 
as nutritious as non-GM soybean varieties, was supported by the outcome of a chicken study (see 
Section 5.1.2.3(b)). The EFSA GMO Panel concludes that the data provided support the view that 
diets formulated with defatted soybean meal derived from soybean MON 87708 are as nutritious as 
those formulated with defatted soybean meal derived from commercial non-GM soybean varieties. 
5.1.5. Post-market monitoring of GM food/feed43 
No data indicating that soybean MON 87708 is any less safe than its conventional counterpart have 
emerged. In addition, soybean MON 87708 is as nutritious as non-GM soybean varieties. Therefore, 
and in line with the Guidance Documents (EFSA, 2006a, 2011a), the EFSA GMO Panel is of the 
opinion that post-market monitoring of the GM food/feed is not necessary. 
5.2. Conclusion 
The DMO proteins are degraded by proteolytic enzymes, and bioinformatics-supported studies 
demonstrated that these proteins show no similarity to known toxic and allergenic proteins. No 
toxicity of the DMO protein was observed in 28-day and acute toxicity studies in mice. The result of a 
90-day feeding study in rats did not raise safety concerns. There are no indications that the genetic 
modification might significantly change the overall allergenicity of soybean MON 87708 when 
compared with that of its conventional counterpart. The compositional data indicating nutritional 
equivalence were corroborated by the chicken study. In conclusion, the EFSA GMO Panel is of the 
opinion that soybean MON 87708 is as safe and as nutritious as its conventional counterpart and non-
GM reference varieties, in the context of its intended use.  
                                                     
41 Directive 2007/68/EC of the European Parliament and of the Council of 27 November 2007 amending Annex IIIa to 
Directive 2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. OJ, L310, 11-14. 
42 Technical dossier/Section D7.10. 
43 Technical dossier/Section D7.11. 
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6. Environmental risk assessment and monitoring plan 
6.1. Evaluation of relevant scientific data 
6.1.1. Environmental risk assessment 
The scope of application EFSA-GMO-NL-2011-93 is for food and feed uses, import and processing 
and does not include cultivation. Considering this scope, the environmental risk assessment is 
concerned with the indirect exposure mainly through manure and faeces from animals fed grain 
produced by soybean MON 87708 and with the accidental release into the environment of viable 
grains produced by soybean MON 87708 during transport and processing. 
As the scope of the present application excludes cultivation, environmental concerns in the EU related 
to the use of dicamba-based herbicides on soybean MON 87708 do not apply.  
6.1.1.1. Unintended effects on plant fitness due to the genetic modification44 
Cultivated soybean (Glycine max (L.) Merr.) is a species in the subgenus Soja of the genus Glycine. 
The species originated from eastern Asia and is a highly domesticated crop (Lu, 2005). The major 
worldwide soybean producers are Argentina, Brazil, China, North Korea, South Korea and the USA. 
In the EU, soybean is mainly cultivated in Italy, France, Romania, Croatia, Hungary and Austria 
(Dorokhov et al. 2004).
45
 Cultivated soybean seeds rarely display any dormancy characteristics, and 
only under certain environmental conditions do they grow as volunteers in the year following 
cultivation. If volunteers occur, they do not compete well with the succeeding crop and can easily be 
controlled mechanically or chemically (OECD, 2000). In soybean fields, seeds usually do not survive 
during the winter owing to predation, rotting, germination resulting in death, or management practices 
prior to planting the subsequent crop (Owen, 2005). The herbicide tolerance trait can be regarded as 
providing only a potential agronomic and selective advantage to this GM soybean plant where and 
when dicamba-based herbicides are applied. However, survival of soybean plants outside cultivation 
where dicamba-based herbicides are applied is limited mainly by a combination of low 
competitiveness, absence of a dormancy phase and susceptibility to plant pathogens and cold climatic 
conditions. As these general characteristics are unchanged in soybean MON 87708, herbicide 
tolerance is not likely to provide a selective advantage outside cultivation. Even if dicamba-based 
herbicides are applied to these plants, this will not change their ability to survive over seasons. 
Therefore, it is considered very unlikely that soybean MON 87708 will differ from conventional 
soybean varieties in its ability to survive until subsequent seasons or to establish feral populations 
under European environmental conditions. 
Laboratory tests and field studies have been carried out to assess the phenotypic and agronomic 
characteristics as well as ecological interactions of GM soybean as described in Section 4.1.3.  
Phenotypic and agronomic traits were evaluated in a field trial across eight locations in the US in 2009 
(for further details, see Section 4.1.3). In addition, ecological interactions, such as soybean 
MON 87708 responses to abiotic and biotic stressors, were evaluated in the same trials. The statistical 
analysis indicated that dicamba-treated and non-treated soybean MON 87708 had lower 100 seed 
weight than its conventional counterpart and the non-GM reference varieties planted in these field 
trials. This parameter therefore required further evaluation (for further details, see Section 4.1.3).  
Germination and dormancy of seeds from soybean MON 87708, its control and non-GM reference 
varieties, produced under different environmental conditions, were evaluated in growth chamber 
experiments following international protocols. Pollen characteristics were also assessed. Although 
some differences were observed under specific environmental conditions, these were not consistent 
and did not indicate a consistent plant response associated with the trait or any change in fitness.  
                                                     
44 Technical dossier/Sections D4, D9.1 and D9.2 and additional information, November 2011. 
45 http://epp.eurostat.ec.europa.eu/portal/page/portal/agriculture/data/database. 
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Considering the intended uses of soybean MON 87708, special attention is paid to those agronomic 
characteristics which may affect the survival, establishment and fitness of soybean MON87708 grains 
which could be accidentally released into the environment: yield, plant height, shattering, germination, 
dormancy. The observed difference in 100 seed weight might result from a differentiated development 
of the crop or might be an indication of unintended effects due to the genetic modification. Regardless, 
this difference is unlikely to be biologically relevant in terms of increased persistence and invasiveness 
potential. 
Therefore, from the data presented in the application, there is no indication of an increased persistence 
and invasiveness potential of soybean MON 87708 compared with conventional soybean, and it can be 
considered that soybean MON 87708 has no altered survival, multiplication or dissemination 
characteristics compared with its conventional counterpart, except under application of dicamba-based 
herbicides.  
In addition to the data presented by the applicant, the EFSA GMO Panel is not aware of any scientific 
report of increased spread and establishment of existing GM soybeans and any change in survival 
capacity, including overwintering (Dorokhov et al., 2004; Owen, 2005; Bagavathiannan and Van 
Acker, 2008; Lee et al., 2009).  
Therefore, the EFSA GMO Panel is of the opinion that the likelihood of unintended environmental 
effects of soybean MON87708 in Europe will not be different to that of conventional soybean 
varieties.  
6.1.1.2. Potential for gene transfer46 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either through horizontal gene transfer of DNA or through vertical gene flow via seed dispersal and 
cross-pollination.  
(a) Plant to bacteria gene transfer  
Genomic DNA is a component of many food and feed products derived from soybean. It is well 
documented that DNA present in food and feed becomes substantially degraded during digestion in the 
human or animal gastrointestinal tract. However, a low level of exposure of fragments of ingested 
DNA, including the recombinant fraction of such DNA, to microorganisms in the digestive tract of 
humans, domesticated animals and other animals feeding on soybean MON87708 is expected.  
Current scientific knowledge of recombination processes in bacteria indicates that horizontal transfer 
of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as plants 
to microorganisms) is not expected to occur at detectable frequencies under natural conditions (see 
EFSA (2009) for further details).   
A successful horizontal transfer would require stable insertion of the transgene sequences into a 
bacterial genome and a selective advantage conferred on the transformed host. The only known 
mechanism that facilitates horizontal transfer of non-mobile, chromosomal DNA fragments into 
bacterial genomes is homologous recombination. This requires the presence of stretches of DNA 
sequences that are similar in the recombining DNA molecules and, in addition to substitutive gene 
replacement, facilitates the insertion of non-homologous DNA sequences if their flanking regions 
share sequence similarity with bacterial sequences in the recipient. 
Soybean MON87708 contains genetic elements with identity or high similarity to those of bacteria. 
The coding sequence of DMO is highly similar to corresponding genes from DMO-producing 
Stenotrophomonas maltophilia, and the flanking regions of the recombinant gene insert contain 
approximately 40- and 250-bp-long sequences of the truncated right and left border, respectively, of 
                                                     
46 Technical dossier/Section D6  
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the Ti plasmid of Agrobacterium tumefaciens. Neither A. tumefaciens nor S. maltophilia is considered 
to be prevalent in the main receiving environment, i.e. the gastrointestinal tract of humans or animals 
(Denton et al., 1998). Both occur in soil, and S. maltophilia has been isolated from the rhizosphere of 
plants (Berg et al., 1996). However, occurrence of the recombinant genes outside their immediate 
receiving environments in the habitats of both bacterial species cannot be ruled out (Hart et al., 2009) 
and is therefore also considered here. 
On a theoretical basis (i.e. without any study providing experimental evidence for horizontal gene 
transfer in the case of GM food and feed derived from soybean MON 87708 or any other GM plant), it 
can be assumed that, as an extremely rare event, homologous recombination can occur between the 
recombinant dmo gene and the dmo gene of S. maltophilia or related bacteria present in the 
environment. Such recombination events would only replace natural variants (i.e. substitutive 
recombination) and are therefore unlikely to provide any new property resulting in a selective 
advantage for the recipient organisms (EFSA, 2009). Homologous recombination of the flanking 
regions with those on Ti plasmids of A. tumefaciens would result in gene replacement, whereby a dmo 
gene would be substituted for genes for crown gall formation (with loss of auxin-, cytokinin- and 
opine-synthesising genes). The current literature suggests that the minimum length of homologous 
DNA necessary to facilitate recombination is 150-bp (De Vries and Wackernagel, 2002; see also 
Annex 1 of EFSA, 2009). Therefore, the flanking regions of the Ti plasmid in the genome of 
MON87708 have a limited potential to facilitate homologous recombination of the recombinant dmo 
gene with naturally occurring Agrobacterium strains carrying Ti plasmids. 
In addition to homology-based recombination processes, illegitimate recombination that does not 
require DNA similarity between the recombining DNA molecules is theoretically possible. However, 
the transformation rates for illegitimate recombination are considered to be 10
10
-fold lower than for 
homologous recombination (Hülter and Wackernagel 2008; EFSA, 2009). Illegitimate recombination 
events have not been detected in studies that have exposed bacteria to high concentrations of GM plant 
DNA (EFSA 2009). Thus, this process, in comparison with homologous recombination, is not 
considered to significantly contribute to horizontal gene transfer events. In comparison with the above 
described homology-facilitated recombination processes, the contribution of illegitimate 
recombination is extremely low. 
The dmo gene of soybean MON87708 is regulated by a promoter of the peanut chlorotic streak 
caulimovirus. The expression of such a promoter–gene construct in bacteria is unknown, but generally 
the expression level of eukaryotic promoters in bacteria is inefficient (Warren et al., 2008).  
In a worst-case scenario, considering the possibility of expression, an A. tumefaciens recipient would 
become capable of producing a DMO protein, but simultaneously it would lose its capacity for crown 
gall formation. The exposure of bacterial communities to the recombinant gene in soybean 
MON87708 must be seen in the context of the natural occurrence and level of exposure to alternative 
sources of similar genes to which bacterial communities are continually exposed. Owing to its specific 
life-style as a soil bacterium and plant pathogen, the EFSA GMO panel considers it unlikely that A. 
tumefaciens would gain selective advantage by acquisition and expression of the dmo gene from 
soybean MON 87708 by homologous recombination.  
The EFSA GMO Panel concludes that the dmo gene from soybean MON87708 may, on a theorical 
basis, be transferred by homologous recombination to A. tumefaciens or to S. maltophilia. However, 
since neither A. tumefaciens nor S. maltophilia is considered to be a member of the gut microbiota, 
exposure to recombinant DNA of soybean MON 87708 is considered to be very low.  
Owing to the occurrence of natural variants of the dmo gene in the environment, a low level of gene 
transfer to A. tumefaciens or S. maltophilia is not regarded to confer a novel selective advantage on 
environmental bacteria as potential recipients. Considering its intended uses as food and feed and the 
above assessment, the EFSA GMO Panel has therefore not identified a concern associated with 
horizontal gene transfer from soybean MON 87708 to bacteria. 
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(b) Plant-to-plant gene transfer 
Considering the intended uses of soybean MON87708 and the physical characteristics of soybean 
seeds, a possible pathway of gene dispersal is from grain spillage and pollen of occasional feral GM 
soybean plants originating from accidental grain spillage during transport and/or processing. 
The genus Glycine is divided into two distinct subgenera: Glycine and Soja. Soybean is in the 
subgenus Soja. The subgenus Glycine contains 16 perennial wild species, whilst the cultivated 
soybean, Glycine max, and its wild and semi-wild annual relatives, Glycine soja and Glycine gracilis, 
are classified in the subgenus Soja (OECD, 2000). Owing to the low level of genomic similarity 
among species of the genus Glycine, Glycine max can cross only with other members of Glycine 
subgenus Soja (Hymowitz et al., 1998; Lu, 2005). Hence, the three species of the subgenus Soja are 
capable of cross-pollination and the hybrid seed that is produced can germinate normally and produce 
plants with fertile pollen and seed (Abe et al., 1999; Nakayama and Yamaguchi, 2002). However, 
since G. soja and G. gracilis are indigenous to Australia, China, Japan, Korea, the Philippines, the far 
eastern region of Russia, the South Pacific and Taiwan, and since they have not been reported in other 
parts of the world where the cultivated soybean is grown (Dorokhov et al. 2004; Lu 2005), plant-to-
plant gene transfer from soybean in the EU is restricted to cultivated soybean. 
Soybean (Glycine max) is an annual almost completely self-pollinating crop; the percentage that is 
cross-pollinated is usually lower than 1% (Weber and Hanson, 1961; Caviness, 1966; Ray et al., 2003; 
Lu, 2005; Yoshimura et al., 2006; Abud et al., 2007). Soybean pollen dispersal is limited because the 
anthers mature in the bud and directly pollinate the stigma of the same flower (OECD, 2000). 
However, cross-pollination rates as high as 6.3% have been reported for closely spaced plants (Ray et 
al., 2003), suggesting the potential of some within-crop gene flow in soybean. These results indicate 
that natural cross-pollination rates can fluctuate significantly among different soybean varieties under 
particular environmental conditions such as favourable climate for pollination and abundance of 
pollinators (Gumisiriza and Rubaihayo, 1978; Kikuchi et al., 1993; Ahrent and Caviness, 1994; Ray et 
al., 2003; Lu, 2005).  
Plant-to-plant gene transfer could therefore occur under the following scenario: imports of soybean 
MON87708 grains (although most MON87708 grains will be processed in the country of production), 
processing outside of importing ports, transport in regions of soybean production in Europe, spillage 
of GM grains during transport, germination and development of spilled grains within soybean fields or 
in the very close vicinity to cultivated soybean fields, overlap of flowering periods and environmental 
conditions favouring cross-pollination. The overall likelihood of cross-pollination between GM 
soybean plants and cultivated soybean is therefore extremely low. Apart from seed production areas, 
GM plants and plants derived from outcrossing with this GM soybean will not persist overtime. 
Dispersal of soybean seeds by animals is not expected because of the characteristics of the seed, but 
accidental release into the environment of grains may occur during transport and processing for food, 
feed and industrial uses. However, cultivated soybean seeds rarely display any dormancy 
characteristics and only under certain environmental conditions will they grow as volunteers in the 
year following cultivation. If volunteers occur they do not compete well with the succeeding crop, and 
can easily be controlled mechanically or chemically (OECD, 2000). Even in soybean fields, seeds 
usually do not survive during the winter owing to predation, rotting, germination resulting in death or 
management practices prior to planting the subsequent crop (Owen, 2005).  
The EFSA GMO Panel takes into account the fact that this application does not include cultivation of 
the soybean within the EU, so that likelihood of cross-pollination between cultivated soybean and 
occasional soybean plants resulting from seed spillage is considered to be extremely low. However, in 
countries cultivating this GM soybean and producing seed for export, there is a potential for admixture 
in seed production and thus the introduction of GM seeds through this route. 
In conclusion, since soybean MON 87708 has no altered survival, multiplication or dissemination 
characteristics, the EFSA GMO Panel is of the opinion that the likelihood of unintended 
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environmental effects as a consequence of spread of genes from this GM soybean in Europe will not 
differ from that of conventional soybean varieties. 
6.1.1.3. Interactions of the GM plant with target organisms47  
Considering the intended uses of soybean MON 87708, excluding cultivation, and the absence of 
target organisms, potential interactions of the GM plant with target organisms were not considered an 
issue by the EFSA GMO Panel. 
6.1.1.4. Interactions of the GM plant with non-target organisms48 
Owing to the intended uses of soybean MON 87708, which exclude cultivation and because of the low 
level of exposure to the environment, potential interactions of the GM plant with non-target organisms 
were not considered an issue by the EFSA GMO Panel. 
6.1.1.5. Interactions with the abiotic environment and biogeochemical cycles49 
Owing to the intended uses of soybean MON 87708, which exclude cultivation and because of the low 
level of exposure to the environment, potential interactions with the abiotic environment and 
biogeochemical cycles were not considered an issue by the EFSA GMO Panel. 
6.1.2. Post-market environmental monitoring50 
The objectives of a post-market environmental monitoring (PMEM) plan according to Annex VII of 
Directive 2001/18/EC are (1) to confirm that any assumptions regarding the occurrence and impact of 
potential adverse effects of the GMO, or its use, in the environmental risk assessment are correct; and 
(2) to identify the occurrence of adverse effects of the GMO, or its use, on human health or the 
environment which were not anticipated in the environmental risk assessment.  
Monitoring is related to risk management, and thus a final adoption of the PMEM plan falls outside 
the mandate of EFSA. However, the EFSA GMO Panel gives its opinion on the scientific content of 
the PMEM plan provided by the applicant (EFSA, 2011). The potential exposure to the environment 
of soybean MON 87708 would be through manure and faeces from animals fed soybean MON 87708 
or through accidental release into the environment of GM soybean grains (e.g. during transport and 
processing). The scope of the PMEM plan provided by the applicant is in line with the intended uses. 
As the environmental risk assessment did not cover cultivation and identified no potential adverse 
environmental effects, no case-specific monitoring is necessary.  
The general surveillance plan proposed by the applicant includes (1) the description of an approach 
involving operators (federations involved in soybean import and processing) reporting to the applicant 
via a centralised system any observed adverse effect(s) of GMOs on human health and the 
environment; (2) a coordinating system established by EuropaBio for the collection of the information 
recorded by the various operators; and (3) the use of networks of existing surveillance systems (Lecoq 
et al. 2007; Windels et al. 2008). The applicant proposes to submit a PMEM report on an annual basis 
and a final report at the end of the consent.  
The EFSA GMO Panel is of the opinion that the scope of the PMEM plan proposed by the applicant is 
in line with the intended uses of soybean MON 87708 as the environmental risk assessment did not 
cover cultivation and identified no potential adverse environmental effects. In addition, the EFSA 
GMO Panel acknowledges the approach proposed by the applicant to put in place appropriate 
management systems to restrict environmental exposure in the case of accidental release of viable 
grains of soybean MON 87708. The EFSA GMO Panel agrees with the reporting intervals proposed 
by the applicant in the PMEM plan.  
                                                     
47 Technical dossier/Sections D8 and D9.4. 
48 Technical dossier/Section D9.5.  
49 Technical dossier/Sections D9.8 and D10.  
50 Technical dossier/Section D11. 
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6.2. Conclusion 
The scope of application EFSA-GMO-NL-2011-93 is for food and feed uses, import and processing 
and does not include cultivation. Considering the intended uses of soybean MON87708, the 
environmental risk assessment is concerned with the indirect exposure mainly through manure and 
faeces from animals fed grain produced by soybean MON 87708 and with the accidental release into 
the environment of viable grains produced by soybean MON 87708 during transport and processing. 
In the event of accidental release into the environment of viable grains of soybean MON 87708 during 
transport and processing, there are no indications of an increased likelihood of establishment and 
spread of feral GM soybean plants, except under application of dicamba-based herbicides. Considering 
its intended uses as food and feed, potential interactions of soybean MON 87708 with the biotic and 
abiotic environment were not considered to be an issue by the EFSA GMO Panel. Furthermore, the 
EFSA GMO Panel is of the opinion that the unlikely but theoretically possible transfer of the 
recombinant gene from soybean MON 87708 to environmental bacteria does not raise concern owing 
to the lack of a selective advantage in the context of its intended uses. 
The scope of the PMEM plan provided by the applicant and the reporting intervals are in line with the 
intended uses of soybean MON 87708 and the Guidance Document of the EFSA GMO Panel on 
PMEM of GM plants (EFSA, 2011). In addition the EFSA GMO Panel acknowledges the approach 
proposed by the applicant to put in place appropriate management systems to restrict environmental 
exposure in cases of accidental release of viable grains of soybean MON 87708. The EFSA GMO 
Panel agrees with the reporting intervals proposed by the applicant in the PMEM plan. 
CONCLUSIONS AND RECOMMENDATIONS 
The EFSA GMO Panel was requested to carry out a scientific risk assessment of soybean MON 87708 
for food and feed uses, import and processing in accordance with Regulation (EC) No 1829/2003.  
The EFSA GMO Panel is of the opinion that the molecular characterisation provided for soybean 
MON 87708 is sufficient. The result of the bioinformatic analyses of the inserted DNA and the 
flanking regions do not raise any safety concerns. The levels of DMO proteins in soybean 
MON 87708 have been sufficiently analysed and the stability of the genetic modification has been 
demonstrated.  
Based on the information available, it is concluded that no differences were identified in the 
compositional data of forage and seeds obtained from soybean MON 87708 or in its agronomic and 
phenotypic characteristics that would require further assessment with regard to safety by the EFSA 
GMO Panel. 
The DMO proteins are degraded by proteolytic enzymes, and bioinformatics-supported studies 
demonstrated that these proteins show no similarity to known toxic and allergenic proteins. No 
toxicity of the DMO protein was observed in 28-day and acute toxicity studies in mice. The result of a 
90-day feeding study in rats with diets containing toasted defatted soybean meal from soybean 
MON 87708, its conventional counterpart or any of two non-GM soybean varieties did not raise safety 
concerns. There are no indications that the genetic modification might significantly change the overall 
allergenicity of soybean MON 87708 when compared with that of its conventional counterpart. The 
compositional data indicating that soybean MON 87708 is as nutritious as non-GM soybean varieties 
were supported by the outcome of a chicken study. The EFSA GMO Panel is of the opinion that 
soybean MON 87708 is as safe and as nutritious as its conventional counterpart and non-GM reference 
varieties, in the context of its intended uses. 
Considering the scope of this application, which excludes cultivation, there is no requirement for 
scientific assessment on possible environmental effects associated with the cultivation of this GM 
soybean. In the case of accidental release into the environment of viable grains of soybean 
MON 87708 during transport and processing, there are no indications of an increased likelihood of 
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establishment and spread of feral GM soybean plants, except under application of dicamba-based 
herbicides. Considering its intended uses as food and feed, potential interactions of soybean 
MON 87708 with the biotic and abiotic environment were not considered to be an issue by the EFSA 
GMO Panel. Furthermore, the EFSA GMO Panel is of the opinion that the unlikely but theoretically 
possible transfer of the recombinant gene from soybean MON 87708 to environmental bacteria does 
not raise concern owing to the lack of a selective advantage in the context of its intended uses. 
The scope of the PMEM plan provided by the applicant and the reporting intervals are in line with the 
intended uses of soybean MON 87708 and the Guidance Documents of the EFSA GMO Panel on 
PMEM of GM plants. In addition, the EFSA GMO Panel acknowledges the approach proposed by the 
applicant to put in place appropriate management systems to restrict environmental exposure in the 
event of accidental release of viable grains of soybean MON 87708. The EFSA GMO Panel agrees 
with the reporting intervals proposed by the applicant in the PMEM plan. 
In conclusion, the EFSA GMO Panel considers that the information available for soybean 
MON 87708 addresses the scientific issues indicated in the relevant Guidance Documents of the EFSA 
GMO Panel and the scientific comments raised by the Member States, and that soybean MON 87708, 
as described in this application, is as safe as its conventional counterpart and non-GM soybean 
reference varieties with respect to potential effects on human and animal health or the environment, in 
the context of its intended uses. 
It should be noted that the assessment of potential consumer health risks resulting from dicamba 
residues and its metabolites in soybean MON 87708 is under the remit of the EFSA Pesticides Unit. 
DOCUMENTATION PROVIDED TO EFSA 
1. Letter from the Competent Authority of the Netherlands received on 9 February 2011 concerning a 
request for placing on the market of soybean MON 87708 in accordance with Regulation (EC) No 
1829/2003. 
2. Acknowledgement letter dated 2 March 2011 from EFSA to the Competent Authority of the 
Netherlands. 
3. Letter from EFSA to applicant, dated 18 March 2011, requesting additional information under 
completeness check.  
4. Letter from applicant to EFSA, received 29 March 2011, providing additional information under 
completeness check. 
5. Letter from EFSA to applicant, dated 13 May 2011, delivering the „Statement of Validity‟ for 
application EFSA-GMO-NL-2011-93, soybean MON 87708 submitted by Monsanto under 
Regulation (EC) No 1829/2003. 
6. Letter from EFSA to applicant dated 10 August 2011 requesting additional information and 
stopping the clock. 
7. Letter from EFSA to applicant dated 17 August 2011 requesting additional information and 
maintaining the clock stopped. 
8. Letter from applicant to EFSA received 18 October 2011 providing additional information. 
9. Letter from EFSA to applicant dated 10 February 2012 requesting additional information and 
maintaining the clock stopped. 
10. Letter from applicant to EFSA received 14 March 2012 providing additional information. 
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11. Letter from EFSA to applicant dated 24 May 2012 re-starting the clock. 
12. Letter from EFSA to applicant dated 5 July 2012 requesting additional information and stopping 
the clock. 
13. Letter from applicant to EFSA received 1 August 2012 providing additional information. 
14. Letter from EFSA to applicant dated 7 November 2012 requesting additional information and 
maintaining the clock stopped. 
15. Letter from applicant to EFSA received 13 November 2012 providing additional information. 
16. Letter from EFSA to applicant dated 11 February 2013 requesting additional information and 
maintaining the clock stopped. 
17. Letter from applicant to EFSA received 15 February 2013 providing additional information. 
18. Letter from EFSA to applicant dated 19 February 2013 requesting additional information and 
maintaining the clock stopped. 
19. Letter from applicant to EFSA received 21 February 2013 providing additional information. 
20. Letter from EFSA to applicant dated 13 May 2013 requesting additional information and 
maintaining the clock stopped. 
21. Letter from applicant to EFSA received 6 June 2013 providing additional information. 
22. Letter from EFSA to applicant dated 5 September 2013 re-starting the clock. 
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